{
 "as_of": "2026-11-02",
 "count": 1,
 "disclaimer": "Factual summary of public SEC filings. Not investment advice. Verify in the original filing.",
 "rows": [
  {
   "accession": "0001493152-26-044381",
   "appeal_by": null,
   "cik": "1855485",
   "company": "Calidi Biotherapeutics, Inc.",
   "days_remaining": -12,
   "deadline": "2026-10-21",
   "deadline_type": "compliance deadline",
   "deficiency": "stockholders' equity",
   "delisting_date": null,
   "exchange": "NYSE American",
   "filed": "2026-09-25",
   "filing_url": "https://www.sec.gov/Archives/edgar/data/1855485/000149315226044381/0001493152-26-044381-index.htm",
   "filings": 1,
   "history": [],
   "notice_date": "2026-09-21",
   "panel": null,
   "status": "Deficiency notice (stated date passed; no later Item 3.01 filing found)",
   "summary": "NYSE American deficiency notice: stockholders' equity; hearing/appeal available; request not stated.",
   "suspension_date": null,
   "ticker": "CLDI",
   "type": "deficiency"
  }
 ],
 "source": "SEC EDGAR 8-K Item 3.01 filings",
 "window_days": 90
}